Thank you for expressing interest in participating in IBD Partners, a patient-centered long-term registry study. “Patient-centered research” means that patients and the inflammatory bowel disease (IBD) research community partner with each other and work as a team. Your input as a patient is critical to the research process. Working together, patients and scientists hope to improve the quality of life for patients with IBD through sharing information and conducting research.
By joining IBD Partners you can contribute to IBD research by completing surveys and providing additional data to help all of us better understand the impact of IBD on patients and the factors that affect the course of the disease. You will also be able to submit and vote on research suggestions and team up with researchers to answer important questions about IBD. In addition, you will be able to use our website to track your health trends and see how your treatments and IBD status compare to that of others in the network.
The Crohn’s & Colitis Foundation is a sponsor of IBD Partners. The Foundation manages a research exchange platform, IBD Plexus (“Plexus”). Plexus is a collection of centralized health information about IBD patients from different research studies. We believe centralizing the data will advance science, accelerate research, and transform the care of patients living with IBD. We are proud to be one of the initial research studies integrating data into Plexus.
Here's who is sponsoring our study:
This research is funded by Crohn’s & Colitis Foundation (the Sponsor).This means that the research team is being paid by the sponsor for doing the study. In addition, Michael Kappelman, a co-investigator on this study, has received money from Crohn’s & Colitis Foundation for work that is not part of this study. These activities may include consulting, service on advisory boards, giving speeches, or writing reports.
A review of these financial arrangements was conducted at the University of North Carolina at Chapel Hill. It was concluded that the possible benefit to the person listed above is not likely to affect your safety or the scientific quality of the study. If you would like more information, please send an email to ccfapartner.org.
Here’s what you can expect:
If you choose to participate, we will ask you to provide information about your disease and treatment by completing online surveys. If you do not feel comfortable answering a survey question, you do not have to answer it. You will also have the option, if you want, to connect a variety of mobile health applications (e.g. Fitbit, Jawbone, etc.) to our patient centered network.
We will touch base with you periodically to let you know about the progress of the program and to provide information about IBD. You can log on to our website to view up-to-date information about the study and update and track your health status. Every 6 months, we will ask you to provide an update about your treatments and health. From time to time, we will let you know about additional research studies for which you might be eligible. You can accept or decline participation at that time.
All data that you enter will be stored in a secure manner and may be retained by IBD Partners and the Crohn’s & Colitis Foundation indefinitely, even after you terminate your account. No personal information will be released to an outside party or disclosed publicly; however, de-identified health data may be used for research purposes. This includes studies that may be funded by non-profit or for-profit entities.
The Crohn’s & Colitis Foundation may contact you for purposes related to its programs and activities such as educational, fundraising, and research opportunities. You can opt out of receiving these emails at any time by unsubscribing to the Crohn’s & Colitis Foundation mailing list.
Here’s what we’ll do:
We will work diligently to protect the health data we collect from you during this study. Neither the Crohn’s & Colitis Foundation nor the IBD Partners research team will ever release your contact information to anyone at any time without your permission. Identifiers, such as your name and address, will not be used in research and will be maintained securely. Any research study associated with new data collection must first undergo review and approval by a project selection committee of expert scientists and IBD patients. Counts of patients who meet certain criteria, are sometimes needed to assist in planning studies. At times we will make this aggregate count data available to qualified researchers prior to committee review.
We will not sell your data to drug companies for market research. Qualified researchers will be able to explore the data in IBD Partners and IBD Plexus for insights into the causes of and potential treatments for IBD. These qualified researchers come from academic, government, non-profit, and for-profit organizations (including pharmaceutical companies) that in some instances contribute funds to the Foundation to support its mission.
You will be able to view the names of IBD Partners researchers who have been granted access to your de-identified data along with a description of the particular research study on the network website. We will also notify you about research findings published in abstracts and scientific papers that used IBD Partners data.
Here’s what you need to know as you get started:
Keep in mind all questions are optional; that is, you don’t have to answer any questions that you don’t want to answer. You can withdraw from the study at any time. We will not associate you with any response in any reports of survey results. There is no cost to you and there is no compensation for taking the survey.
Again thank you for helping us. We believe this project has excellent long-term potential to improve our understanding of IBD and the quality of life for patients with IBD.